C反応性タンパク質試験の世界市場:アッセイタイプ別、検出範囲別、疾患領域別(癌、子宮内膜症、心血管疾患)、最終用途別

◆英語タイトル:C-Reactive Protein Testing Market Size, Share & Trends Analysis Report By Assay Type, By Detection Range, By Disease Area (Cancer, Endometriosis, Cardiovascular Diseases), By End Use, And Segment Forecasts, 2020 - 2027
◆商品コード:GV20MY044
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2020年4月30日
◆ページ数:112
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥624,750見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥729,750見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥939,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、C反応性タンパク質試験の世界市場について調査・分析し、調査手法、エグゼクティブサマリー、市場要因・動向・範囲、種類別(免疫比濁法、ELISA、化学発光免疫測定法、その他)分析、検出範囲別(hs-CRP、従来型CRP、心臓型CRP(cCRP))分析、疾患領域別(がん、関節リウマチ、炎症性腸疾患、子宮内膜症、ループス、その他)分析、最終種類別(クリニック、病院、検査室、生活支援医療施設、ホーム、その他)分析、地域別分析、競争状況などの構成でお届けいたします。
・調査手法
・エグゼクティブサマリー
・市場要因・動向・範囲
・C反応性タンパク質試験の世界市場:種類別(免疫比濁法、ELISA、化学発光免疫測定法、その他)
・C反応性タンパク質試験の世界場:検出範囲別(hs-CRP、従来型CRP、心臓型CRP(cCRP))
・C反応性タンパク質試験の世界市場:疾患領域別(がん、関節リウマチ、炎症性腸疾患、子宮内膜症、ループス、その他)
・C反応性タンパク質試験の世界市場:最終種類別(クリニック、病院、検査室、生活支援医療施設、ホーム、その他)
・C反応性タンパク質試験の世界市場:地域別
・競争状況
【レポートの概要】

The global C-reactive protein testing market size is expected to reach USD 1.9 billion by 2027, growing at a CAGR of 1.3% during the forecast period, according to a new report by Grand View Research, Inc. Several studies have shown the role of C-reactive proteins as an inflammatory marker in gastrointestinal diseases. This has accelerated the reliance on these proteins for the diagnosis of a disease like Crohn’s disease and acute pancreatitis. The initiatives undertaken by government agencies to increase awareness as well as uptake of point-of-care are factors driving the market.

The rising prevalence of gastrointestinal diseases coupled with subsequent demand for robust disease testing protocols has driven the market to a considerable extent. POC based CRP testing within healthcare settings and among patients drives market growth. For instance, the National Institute for Health and Care Excellence has recommended the usage of POC CRP testing in primary care for adult patients diagnosed with respiratory tract infections.

Increase in funds and investments for research entities that are engaged in performing research activities in this area, boost market progression. The National Institute for Health Research, the Wellcome Trust, and the Department for International Development are among the few funding agencies engaged in supporting C-reactive protein tests related research activities.

Further key findings from the report suggest:

• Immunoturbidimetric assay segment accounted for the maximum revenue share in 2019 and is anticipated to maintain its dominance during the forecast period

• This is attributive to the introduction of less expensive automated and highly sensitive immunoturbidimetric assays that have a wide measuring range for CRP levels

• High sensitivity C-reactive protein accounted for the major revenue share in 2019 owing to their efficiency in delivering results with high accuracy as compared to the conventional assays

• CRP is one of the important biomarkers that play a direct role in promoting vessel damage, vascular inflammation, and other clinical cardiovascular events

• This has resulted in the high adoption rate of these tests for the detection of cardiovascular diseases, as compared to other disease areas

• The high usage rate of these tests within clinical settings is attributive to the largest revenue share of clinics due to an increase in the number of patient visits in clinics

• The clinics, including physician offices, outpatient clinics, and community health centers conduct these tests at an affordable cost in minimal time, resulting in the largest share

• North America dominated the C-reactive protein testing market due to the presence of agencies, such as the American College of Cardiology Foundation, which raises awareness for the preliminary screening of inflammatory disorders, thereby positively influencing the uptake of these tests

• Asia Pacific is anticipated to witness the fastest CAGR owing to the ongoing research studies pertaining CRP testing in the Asian countries, which promotes the adoption of these tests in this region

• Quest Diagnostics, Siemens, Danaher, Abbott, Roche, and Thermo Fisher Scientific are some key companies operating in the market

• These companies are expanding their product portfolio and distribution network through partnership and agreement models to reinforce their market presence

• For instance, in May 2018, Ortho Clinical Diagnostics signed an agreement with Sentinel Diagnostics to develop CRP Ultra (MP) Assay for future CRP testing in hospitals and laboratories.

【レポートの目次】

Table of Contents

Chapter 1 Executive Summary
1.1 Market Overview
1.2 Market Segmentation & Scope
1.3 Competitive Insights
Chapter 2 Research Methodology
2.1 Information Procurement
2.1.1 Purchased database:
2.1.2 GVR’s internal database
2.1.3 Secondary sources:
2.1.4 Primary research:
2.1.5 Details of primary research
2.2 Information or Data Analysis
2.2.1 Data analysis models
2.3 Market Formulation & Validation
2.4 Model Details
2.4.1 Commodity flow analysis (Model 1)
2.4.1.1 Approach 1: Commodity flow approach
2.4.2 Volume price analysis (Model 2)
2.4.2.1 Approach 2: Volume price analysis
2.5 List of Secondary Sources
2.6 List of Primary Sources
2.7 Objectives
2.7.1 Objective 1
2.7.2 Objective 2
Chapter 3 Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market driver analysis
3.1.1.1 Increasing R&D in the field of C-reactive protein testing
3.1.1.2 Rising incidence of chronic disorders
3.1.2 Market restraint analysis
3.1.2.1 Availability of alternative disease testing methods
3.2 Opportunity Analysis
3.2.1 Technological advancements pertaining to conventional CRP tests
3.2.2 Growing adoption of point-of-care tests
3.3 Threat Analysis
3.3.1 Threat analysis on conventional CRP tests
3.4 Penetration & Growth Prospect Mapping for Assay Type, 2019
3.5 C-reactive Protein (CRP) Testing Market-SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
3.6 IndustryAnalysis – Porter’s
Chapter 4 C-reactive Protein (CRP) Testing Market: Assay Type Estimates & Trend Analysis
4.1 C-Reactive Protein Testing Market: Assay Type Movement Analysis
4.2 Immunoturbidimetric Assay
4.2.1 Global immunoturbidimetric assay market, 2016 – 2027 (USD Million)
4.3 ELISA
4.3.1 Global ELISA market, 2016 – 2027 (USD Million)
4.3.2 Clinical ELISA
4.3.2.1 Global clinical ELISA market, 2016 – 2027 (USD Million)
4.3.3 Nonclinical ELISA
4.3.3.1 Global nonclinical ELISA market, 2016 – 2027 (USD Million)
4.4 Chemiluminescence Immunoassay
4.4.1 Global Chemiluminescence Immunoassay market, 2016 – 2027 (USD Million)
4.5 Others
4.5.1 Global other assay types market, 2016 – 2027 (USD Million)
Chapter 5 C-reactive Protein (CRP) Testing Market: Detection Range Estimates & Trend Analysis
5.1 C-Reactive Protein Testing Market: Detection Range Movement Analysis
5.2 High Sensitivity C-reactive Protein (hs-CRP)
5.2.1 Global hsCRP market, 2016 – 2027 (USD Million)
5.3 Conventional CRP
5.3.1 Global conventional CRP market, 2016 – 2027 (USD Million)
5.4 Cardiac CRP (cCRP)
5.4.1 Global cardiac CRP market, 2016 – 2027 (USD Million)
Chapter 6 C-reactive Protein (CRP) Testing Market: Disease Area Estimates & Trend Analysis
6.1 C-Reactive Protein Testing Market: Disease Area Movement Analysis
6.2 Cardiovascular Diseases
6.2.1 Global cardiovascular diseases CRP testing market, 2016 – 2027 (USD Million)
6.3 Cancer
6.3.1 Global cancer CRP testing market, 2016 – 2027 (USD Million)
6.4 Rheumatoid Arthritis
6.4.1 Global rheumatoid arthritis CRP testing market, 2016 – 2027 (USD Million)
6.5 Inflammatory Bowel Disease
6.5.1 Global inflammatory bowel disease CRP testing market, 2016 – 2027 (USD Million)
6.6 Endometriosis
6.6.1 Global endometriosis CRP testing market, 2016 – 2027 (USD Million)
6.7 Lupus
6.7.1 Global lupus CRP testing market, 2016 – 2027 (USD Million)
6.8 Others
6.8.1 Global others market, 2016 – 2027 (USD Million)
Chapter 7 C-reactive Protein (CRP) Testing Market: End-use Estimates & Trend Analysis
7.1 C-Reactive Protein Testing Market: End-use Movement Analysis
7.2 Clinics
7.2.1 Global clinics market, 2016 – 2027 (USD Million)
7.2.2 Clinics, by entity
7.2.2.1 Physician offices
7.2.2.1.1 Global physician offices market, 2016 – 2027 (USD Million)
7.2.2.2 Small clinics
7.2.2.2.1 Global small clinics market, 2016 – 2027 (USD Million)
7.2.2.3 Others
7.2.2.3.1 Global other clinics market, 2016 – 2027 (USD Million)
7.2.3 Clinics, by settings
7.2.3.1 Urban settings
7.2.3.1.1 Global urban setting clinics market, 2016 – 2027 (USD Million)
7.2.3.2 Rural settings
7.2.3.2.1 Global rural settings clinic market, 2016 – 2027 (USD Million)
7.3 Hospitals
7.3.1 Global hospitals market, 2016 – 2027 (USD Million)
7.3.2 Urban setting
7.3.2.1 Global urban setting hospitals market, 2016 – 2027 (USD Million)
7.3.3 Rural setting
7.3.3.1 Global rural setting hospitals market, 2016 – 2027 (USD Million)
7.4 Laboratories
7.4.1 Global laboratories market, 2016 – 2027 (USD Million)
7.4.2 Urban setting
7.4.2.1 Global urban setting laboratories market, 2016 – 2027 (USD Million)
7.4.3 Rural setting
7.4.3.1 Global rural setting laboratories market, 2016 – 2027 (USD Million)
7.5 Assisted Living Healthcare Facilities
7.5.1 Global assisted living healthcare facilities market, 2016 – 2027 (USD Million)
7.5.2 Urban setting
7.5.2.1 Global urban setting assisted living healthcare facilities market, 2016 – 2027 (USD Million)
7.5.3 Rural setting
7.5.3.1 Global rural setting assisted living healthcare facilities market, 2016 – 2027 (USD Million)
7.6 Home
7.6.1 Global home market, 2016 – 2027 (USD Million)
7.7 Others
7.7.1 Global others market, 2016 – 2027 (USD Million)
Chapter 8 C-reactive Protein (CRP) Testing Market: Regional Estimates & Trend Analysis by Assay, Detection Area, Disease Area, & End-use
8.1 C-Reactive Protein Testing Market Share by Region, 2019 & 2027
8.2 North America
8.2.1 North America C-reactive protein testing market, 2016 – 2027 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. C-reactive protein testing market, by assay type, 2016 – 2027 (USD Million)
8.2.2.2 U.S. C-reactive protein testing market, by detection range, 2016 – 2027 (USD Million)
8.2.2.3 U.S. C-reactive protein testing market, by disease area, 2016 – 2027 (USD Million)
8.2.2.4 U.S. C-reactive protein testing market, by end use, 2016 – 2027 (USD Million)
8.2.3 Canada
8.2.3.1 Canada C-reactive protein testing market, by assay type, 2016 – 2027 (USD Million)
8.2.3.2 Canada C-reactive protein testing market, by detection range, 2016 – 2027 (USD Million)
8.2.3.3 Canada C-reactive protein testing market, by disease area, 2016 – 2027 (USD Million)
8.2.3.4 Canada C-reactive protein testing market, by end use, 2016 – 2027 (USD Million)
8.3 Europe
8.3.1 Europe C-reactive protein testing market, 2016 – 2027 (USD Million)
8.3.2 Germany
8.3.2.1 Germany C-reactive protein testing market, by assay type, 2016 – 2027 (USD Million)
8.3.2.2 Germany C-reactive protein testing market, by detection range, 2016 – 2027 (USD Million)
8.3.2.3 Germany C-reactive protein testing market, by disease area, 2016 – 2027 (USD Million)
8.3.2.4 Germany C-reactive protein testing market, by end use, 2016 – 2027 (USD Million)
8.3.3 U.K.
8.3.3.1 U.K. C-reactive protein testing market, by assay type, 2016 – 2027 (USD Million)
8.3.3.2 U.K. C-reactive protein testing market, by detection range, 2016 – 2027 (USD Million)
8.3.3.3 U.K. C-reactive protein testing market, by disease area, 2016 – 2027 (USD Million)
8.3.3.4 U.K. C-reactive protein testing market, by end use, 2016 – 2027 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific C-reactive protein testing market, 2016 – 2027 (USD Million)
8.4.2 Japan
8.4.2.1 Japan C-reactive protein testing market, by assay type, 2016 – 2027 (USD Million)
8.4.2.2 Japan C-reactive protein testing market, by detection range, 2016 – 2027 (USD Million)
8.4.2.3 Japan C-reactive protein testing market, by disease area, 2016 – 2027 (USD Million)
8.4.2.4 Japan C-reactive protein testing market, by end use, 2016 – 2027 (USD Million)
8.4.3 China
8.4.3.1 China C-reactive protein testing market, by assay type, 2016 – 2027 (USD Million)
8.4.3.2 China C-reactive protein testing market, by detection range, 2016 – 2027 (USD Million)
8.4.3.3 China C-reactive protein testing market, by disease area, 2016 – 2027 (USD Million)
8.4.3.4 China C-reactive protein testing market, by end use, 2016 – 2027 (USD Million)
8.5 Latin America
8.5.1 Latin America C-reactive protein testing market, 2016 – 2027 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil C-reactive protein testing market, by assay type, 2016 – 2027 (USD Million)
8.5.2.2 Brazil C-reactive protein testing market, by detection range, 2016 – 2027 (USD Million)
8.5.2.3 Brazil C-reactive protein testing market, by disease area, 2016 – 2027 (USD Million)
8.5.2.4 Brazil C-reactive protein testing market, by end use, 2016 – 2027 (USD Million)
8.6 Middle East & Africa (MEA)
8.6.1 Middle East & Africa C-reactive protein testing market, 2016 – 2027 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa C-reactive protein testing market, by assay type, 2016 – 2027 (USD Million)
8.6.2.2 South Africa C-reactive protein testing market, by detection range, 2016 – 2027 (USD Million)
8.6.2.3 South Africa C-reactive protein testing market, by disease area, 2016 – 2027 (USD Million)
8.6.2.4 South Africa C-reactive protein testing market, by end use, 2016 – 2027 (USD Million)
Chapter 9 Competitive Landscape
9.1 Company Categorization
9.2 Recent Developments & Impact Analysis, by Key Market Participants
9.3 Public Companies
9.3.1 Company market position analysis
9.4 Private Companies
9.4.1 List of key emerging companies
9.5 Strategy Framework
9.6 Company Profiles
9.6.1 Thermo Fisher Scientific, Inc.
9.6.1.1 Company overview
9.6.1.2 Financial performance
9.6.1.3 Product benchmarking
9.6.2.4 Strategic initiatives
9.6.2 F. Hoffmann-La Roche Ltd.
9.6.2.1 Company overview
9.6.2.2 Financial performance
9.6.2.3 Product benchmarking
9.6.2.4 Strategic initiatives
9.6.3 Danaher
9.6.3.1 Company overview
9.6.3.1.1 Beckman Coulter, Inc.
9.6.3.1.2 Radiometer
9.6.3.2 Financial performance
9.6.3.3 Product benchmarking
9.6.3.4 Strategic initiatives
9.6.4 Quest Diagnostics Incorporated
9.6.4.1 Company overview
9.6.4.2 Financial performance
9.6.4.3 Product benchmarking
9.6.4.4 Strategic initiatives
9.6.5 Siemens
9.6.5.1 Company overview
9.6.5.2 Financial performance
9.6.5.3 Product benchmarking
9.6.5.4 Strategic initiatives
9.6.6 Abbott Laboratories
9.6.5.1 Company overview
9.6.6.1.1 Alere Inc.
9.6.6.2 Financial performance
9.6.6.3 Product benchmarking
9.6.6.4 Strategic initiatives
9.6.7 Laboratory Corporation of America Holdings (LabCorp)
9.6.7.1 Company overview
9.6.7.2 Financial performance
9.6.7.3 Product benchmarking
9.6.7.4 Strategic initiatives
9.6.8 Merck KGaA
9.6.8.1 Company overview
9.6.8.1.1 Sigma-Aldrich Co. LLC
9.6.8.1.2 Merck Millipore
9.6.8.2 Financial performance
9.6.8.3 Product benchmarking
9.6.8.4 Strategic initiatives
9.6.9 Abaxis, Inc.
9.6.9.1 Company overview
9.6.9.2 Financial performance
9.6.9.3 Product benchmarking
9.6.9.4 Strategic initiatives
9.6.10 Ortho Clinical Diagnostics
9.6.10.1 Company overview
9.6.10.2 Financial performance
9.6.10.3 Product benchmarking
9.6.10.4 Strategic initiatives
9.6.11 Getein Biotech, Inc.
9.6.11.1 Company overview
9.6.11.2 Financial performance
9.6.11.3 Product benchmarking
9.6.12 HORIBA, Ltd.
9.6.12.1 Company overview
9.6.12.2 Financial performance
9.6.12.3 Product benchmarking
9.6.12.4 Strategic initiatives
9.6.13 Randox Laboratories Ltd.
9.6.13.1 Company overview
9.6.13.2 Financial performance
9.6.13.3 Product benchmarking
9.6.13.4 Strategic initiatives
9.6.14 BODITECH MED, INC
9.6.14.1 Company overview
9.6.14.2 Financial performance
9.6.14.3 Product benchmarking
9.6.14.4 Strategic initiatives
9.6.15 Aidian
9.6.15.1 Company overview
9.6.15.2 Financial performance
9.6.15.3 Product benchmarking
9.6.15.4 Strategic initiatives
9.6.16 Eurolyser Diagnostica GmbH
9.6.16.1 Company overview
9.6.16.2 Financial performance
9.6.16.3 Product benchmarking
9.6.16.4 Strategic initiatives
9.6.17 Abcam plc
9.6.17.1 Company overview
9.6.17.2 Financial performance
9.6.17.3 Product benchmarking
9.6.17.4 Strategic initiatives
9.6.18 Bio-Techne
9.6.18.1 Company overview
9.6.18.2 Financial performance
9.6.18.3 Product benchmarking
9.6.18.4 Strategic initiatives
9.6.19 EKF Diagnostics
9.6.19.1 Company overview
9.6.19.2 Financial performance
9.6.19.3 Product benchmarking
9.6.19.4 Strategic initiatives
9.6.20 SD Biosensor, INC.
9.6.20.1 Company overview
9.6.20.2 Financial performance
9.6.20.3 Product benchmarking
9.6.20.4 Strategic initiatives

List of Tables

TABLE 1 Customer relationship management market - Industry snapshot & key buying criteria, 2016 - 2027
TABLE 2 Global customer relationship management market, 2016 - 2027 (USD Billion)
TABLE 3 Global customer relationship management market, by region 2016 - 2027 (USD Billion)
TABLE 4 Global customer relationship management market, by solution, 2016 - 2027 (USD Billion)
TABLE 5 Global customer relationship management market, by deployment, 2016 - 2027 (USD Billion)
TABLE 6 Global customer relationship management market, by enterprise size, 2016 - 2027 (USD Billion)
TABLE 7 Global customer relationship management market, by end use, 2016 - 2027 (USD Billion)
TABLE 8 Customer relationship management market - Key developments
TABLE 9 Customer relationship management - Company ranking
TABLE 10 Customer relationship management - Key market driver impact
TABLE 11 Customer relationship management - Key market restraint impact
TABLE 12 CRM customer service market, 2016 - 2027 (USD Billion)
TABLE 13 CRM customer service market, by region 2016 - 2027 (USD Billion)
TABLE 14 CRM customer experience management market, 2016 - 2027 (USD Billion)
TABLE 15 CRM customer experience management market , by region 2016 - 2027 (USD Billion)
TABLE 16 CRM analytics market, 2016 - 2027 (USD Billion)
TABLE 17 CRM analytics market, by region 2016 - 2027 (USD Billion)
TABLE 18 CRM marketing automation market, 2016 - 2027 (USD Billion)
TABLE 19 CRM marketing automation market, by region, 2016 - 2027 (USD Billion)
TABLE 20 CRM salesforce automation market, 2016 - 2027 (USD Billion)
TABLE 21 CRM salesforce automation market, by region, 2016 - 2027 (USD Billion)
TABLE 22 CRM social media monitoring market, 2016 - 2027 (USD Billion)
TABLE 23 CRM social media monitoring market, by region, 2016 - 2027 (USD Billion)
TABLE 24 Other CRM solutions market, 2016 - 2027 (USD Billion)
TABLE 25 Other CRM solutions market, by region, 2016 - 2027 (USD Billion)
TABLE 26 On-premise customer relationship management market, 2016 - 2027 (USD Billion)
TABLE 27 On-premise customer relationship management market, by region, 2016 - 2027 (USD Billion)
TABLE 28 Cloud customer relationship management market, 2016 - 2027 (USD Billion)
TABLE 29 Cloud customer relationship management market, by region, 2016 - 2027 (USD Billion)
TABLE 30 Customer relationship management market in large enterprises, 2016 - 2027 (USD Billion)
TABLE 31 Customer relationship management market in large enterprises, by region, 2016 - 2027 (USD Billion)
TABLE 32 Customer relationship management market in Small and Medium Enterprise, 2016 - 2027 (USD Billion)
TABLE 33 Customer relationship management market in Small and Medium Enterprise, by region, 2016 - 2027 (USD Billion)
TABLE 34 Customer relationship management market in BFSI, 2016 - 2027 (USD Billion)
TABLE 35 Customer relationship management market in BFSI, by region 2016 - 2027 (USD Billion)
TABLE 36 Customer relationship management market in retail, 2016 - 2027 (USD Billion)
TABLE 37 Customer relationship management market in retail, by region 2016 - 2027 (USD Billion)
TABLE 38 Customer relationship management market in healthcare, 2016 - 2027 (USD Billion)
TABLE 39 Customer relationship management market in healthcare, by region 2016 - 2027 (USD Billion)
TABLE 40 Customer relationship management market in telecom & IT, 2016 - 2027 (USD Billion)
TABLE 41 Customer relationship management market in telecom & IT, by region, 2016 - 2027 (USD Billion)
TABLE 42 Customer relationship management market in discrete manufacturing, 2016 - 2027 (USD Billion)
TABLE 43 Customer relationship management market in discrete manufacturing, by region, 2016 - 2027 (USD Billion)
TABLE 44 Customer relationship management market in government & education, 2016 - 2027 (USD Billion)
TABLE 45 Customer relationship management market in government & education, by region, 2016 - 2027 (USD Billion)
TABLE 46 Customer relationship management market in other applications, 2016 - 2027 (USD Billion)
TABLE 47 Customer relationship management market in other applications, by region, 2016 - 2027 (USD Billion)
TABLE 48 North America customer relationship management market, by solution, 2016 - 2027 (USD Billion)
TABLE 49 North America customer relationship management market, by deployment, 2016 - 2027 (USD Billion)
TABLE 50 North America customer relationship management market, by enterprise size, 2016 - 2027 (USD Billion)
TABLE 51 North America customer relationship management market, by end use, 2016 - 2027 (USD Billion)
TABLE 52 U.S. customer relationship management market, by solution, 2016 - 2027 (USD Billion)
TABLE 53 U.S. customer relationship management market, by deployment, 2016 - 2027 (USD Billion)
TABLE 54 U.S. customer relationship management market, by enterprise size, 2016 - 2027 (USD Billion)
TABLE 55 U.S. customer relationship management market, by end use, 2016 - 2027 (USD Billion)
TABLE 56 Canada customer relationship management market, by solution, 2016 - 2027 (USD Billion)
TABLE 57 Canada customer relationship management market, by deployment, 2016 - 2027 (USD Billion)
TABLE 58 Canada customer relationship management market, by enterprise size, 2016 - 2027 (USD Billion)
TABLE 59 Canada customer relationship management market, by end use, 2016 - 2027 (USD Billion)
TABLE 60 Europe customer relationship management market, by solution, 2016 - 2027 (USD Billion)
TABLE 61 Europe customer relationship management market, by deployment, 2016 - 2027 (USD Billion)
TABLE 62 Europe customer relationship management market, by enterprise size, 2016 - 2027 (USD Billion)
TABLE 63 Europe customer relationship management market, by end use, 2016 - 2027 (USD Billion)
TABLE 64 U.K. customer relationship management market, by solution, 2016 - 2027 (USD Billion)
TABLE 65 U.K. customer relationship management market, by deployment, 2016 - 2027 (USD Billion)
TABLE 66 U.K. customer relationship management market, by enterprise size, 2016 - 2027 (USD Billion)
TABLE 67 U.K. customer relationship management market, by end use, 2016 - 2027 (USD Billion)
TABLE 68 Germany customer relationship management market, by solution, 2016 - 2027 (USD Billion)
TABLE 69 Germany customer relationship management market, by deployment, 2016 - 2027 (USD Billion)
TABLE 70 Germany customer relationship management market, by enterprise size, 2016 - 2027 (USD Billion)
TABLE 71 Germany customer relationship management market, by end use, 2016 - 2027 (USD Billion)
TABLE 72 Asia Pacific customer relationship management market, by solution, 2016 - 2027 (USD Billion)
TABLE 73 Asia Pacific customer relationship management market, by deployment, 2016 - 2027 (USD Billion)
TABLE 74 Asia Pacific customer relationship management market, by enterprise size, 2016 - 2027 (USD Billion)
TABLE 75 Asia Pacific customer relationship management market, by end use, 2016 - 2027 (USD Billion)
TABLE 76 China customer relationship management market, by solution, 2016 - 2027 (USD Billion)
TABLE 77 China customer relationship management market, by deployment, 2016 - 2027 (USD Billion)
TABLE 78 China customer relationship management market, by enterprise size, 2016 - 2027 (USD Billion)
TABLE 79 China customer relationship management market, by end use, 2016 - 2027 (USD Billion)
TABLE 80 India customer relationship management market, by solution, 2016 - 2027 (USD Billion)
TABLE 81 India customer relationship management market, by deployment, 2016 - 2027 (USD Billion)
TABLE 82 India customer relationship management market, by enterprise size, 2016 - 2027 (USD Billion)
TABLE 83 India customer relationship management market, by end use, 2016 - 2027 (USD Billion)
TABLE 84 Japan customer relationship management market, by solution, 2016 - 2027 (USD Billion)
TABLE 85 Japan customer relationship management market, by deployment, 2016 - 2027 (USD Billion)
TABLE 86 Japan customer relationship management market, by enterprise size, 2016 - 2027 (USD Billion)
TABLE 87 Japan customer relationship management market, by end use, 2016 - 2027 (USD Billion)
TABLE 88 Latin America customer relationship management market, by solution, 2016 - 2027 (USD Billion)
TABLE 89 Latin America customer relationship management market, by deployment, 2016 - 2027 (USD Billion)
TABLE 90 Latin America customer relationship management market, by enterprise size, 2016 - 2027 (USD Billion)
TABLE 91 Latin America customer relationship management market, by end use, 2016 - 2027 (USD Billion)
TABLE 92 Brazil customer relationship management market, by solution, 2016 - 2027 (USD Billion)
TABLE 93 Brazil customer relationship management market, by deployment, 2016 - 2027 (USD Billion)
TABLE 94 Brazil customer relationship management market, by enterprise size, 2016 - 2027 (USD Billion)
TABLE 95 Brazil customer relationship management market, by end use, 2016 - 2027 (USD Billion)
TABLE 96 MEA customer relationship management market, by solution, 2016 - 2027 (USD Billion)
TABLE 97 MEA customer relationship management market, by deployment, 2016 - 2027 (USD Billion)
TABLE 98 MEA customer relationship management market, by enterprise size, 2016 - 2027 (USD Billion)
TABLE 99 MEA customer relationship management market, by end use, 2016 - 2027 (USD Billion)

List of Figures

FIG. 1 Market segmentation and scope
FIG. 2 Customer relationship management market, 2016 - 2027 (USD Billion)
FIG. 3 Customer relationship management - Value chain analysis
FIG. 4 Customer relationship management - Market dynamics
FIG. 5 Global customer relationship management market - Company ranking analysis
FIG. 6 Key opportunities prioritized
FIG. 7 Customer relationship management market - Porter’s five forces analysis
FIG. 8 Customer relationship management market - PESTEL analysis
FIG. 9 Customer relationship management market share, by solution, 2019 & 2027
FIG. 10 Customer relationship management market share, by deployment, 2019 & 2027
FIG. 11 Customer relationship management market share, by enterprise size, 2019 & 2027
FIG. 12 Customer relationship management market share, by end use, 2019 & 2027
FIG. 13 Customer relationship management market share, by region, 2019 & 2027
FIG. 14 Regional market place - Key takeaways
FIG. 15 North America customer relationship management market - Key takeaways
FIG. 16 Europe customer relationship management market - Key takeaways
FIG. 17 Asia Pacific customer relationship management market - Key takeaways
FIG. 18 Latin America customer relationship management market - Key takeaways
FIG. 19 MEA customer relationship management market - Key takeaways

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[C反応性タンパク質試験の世界市場:アッセイタイプ別、検出範囲別、疾患領域別(癌、子宮内膜症、心血管疾患)、最終用途別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆